moxifloxacin has been researched along with Tachycardia, Ventricular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, Y; Park, HS | 1 |
| Friedrich, S; Krueger, KA; Suico, JG; Zhang, W | 1 |
| Baas, T; Dössel, O; Gräfe, K; Khawaja, A | 1 |
1 trial(s) available for moxifloxacin and Tachycardia, Ventricular
| Article | Year |
|---|---|
Evacetrapib at a supratherapeutic steady state concentration does not prolong QT in a thorough QT/QTc study in healthy participants.
Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Benzodiazepines; Body Mass Index; Cholesterol Ester Transfer Proteins; Cross-Over Studies; Dose-Response Relationship, Drug; Electrocardiography; Female; Fluoroquinolones; Half-Life; Humans; Male; Moxifloxacin; Tachycardia, Ventricular | 2014 |
2 other study(ies) available for moxifloxacin and Tachycardia, Ventricular
| Article | Year |
|---|---|
Association of oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin with the risk of serious ventricular arrhythmia: a nationwide cohort study in Korea.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Arrhythmias, Cardiac; Cefixime; Ciprofloxacin; Cohort Studies; Female; Fluoroquinolones; Heart Arrest; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Protective Factors; Republic of Korea; Risk Factors; Tachycardia, Ventricular; Ventricular Fibrillation; Ventricular Flutter | 2018 |
Investigation of parameters highlighting drug induced small changes of the T-wave's morphology for drug safety studies.
Topics: Anti-Infective Agents; Aza Compounds; Electrocardiography; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Quinolines; Tachycardia, Ventricular; Torsades de Pointes; United States; United States Food and Drug Administration | 2011 |